Phase 1b/2 Study of LDRT in Combination With AK104 Plus Chemotherapy as First-line Treatment for ES-SCLC
Clinical trial NCT06477523 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06477523
- Sponsor
- Sichuan University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-16
- Primary completion
- 2026-12-31
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.